Conducting clinical trials in the Czech Republic with Cromos Pharma
Cromos Pharma has been managing clinical trials in the Czech Republic since the 2010s and established a permanent office in its capital Prague in 2015. Czechia is recognized as an attractive location for international clinical trials with a strong track record for producing high-quality data and lengthy experience in Good Clinical Practices provided by the ICH-GCP.
Cromos Pharma successfully completes enrollment for a Phase II COVID-19 vaccine clinical trial
Cromos Pharma today (Thursday, 16 September, 2021) announced that it has successfully completed recruitment for a Phase II COVID-19 vaccine clinical trial. Cromos Pharma is pleased to achieve this important milestone for this vaccine study which will contribute to the ongoing fight against the COVID-19 pandemic. This enrollment is the latest success for Cromos Pharma, a US-based
Cromos Pharma committed to supporting clinical research into Alzheimer’s disease
This September Cromos Pharma is highlighting World Alzheimer’s Month. Alzheimer’s Disease (AD) is the most well-known form of dementia. Dementia is the collective name for progressive brain conditions affecting memory, thinking, behavior and emotions. Dementia affects almost 50 million people worldwide. While aging is a major risk factor for dementia, it also affects people under 65 years. There are over
